Research Article
Changes of Electrocardiogram and Myocardial Enzymes in Patients with Intracerebral Hemorrhage
Table 4
Univariate analysis of elevated myocardial enzymes in ICH. Significant values (
) are in bold.
| Variable | Entire cohort () | Elevated CK () | value | Elevated CKMB () | value | Elevated LDH () | value | Elevated hs-cTnT () | value |
| Age (SD) | 61.23 (13.64) | 60.58 (13.63) | 0.675 | 58.42 (13.57) | 0.070 | 59.66 (14.20) | 0.200 | 64.91 (14.81) | 0.003 | Male (%) | 136 (65.38) | 42 (73.68) | 0.122 | 43 (75.44) | 0.061 | 49 (61.25) | 0.322 | 51 (64.56) | 0.844 | History of hypertension | 140 (67.31) | 39 (68.42) | 0.833 | 39 (68.42) | 0.833 | 54 (67.50) | 0.963 | 57 (72.15) | 0.244 | History of type 2 diabetes | 16 (7.69) | 5 (8.77) | 0.720 | 4 (7.02) | 0.822 | 4 (5.00) | 0.249 | 11 (13.92) | 0.008 | History of cerebrovascular diseases | 32 (15.38) | 12 (21.05) | 0.164 | 10 (17.54) | 0.596 | 10 (12.50) | 0.362 | 14 (17.72) | 0.465 | History of coronary heart disease | 11 (5.29) | 3 (5.26) | 0.992 | 4 (7.02) | 0.494 | 5 (6.25) | 0.624 | 7 (8.86) | 0.072 | History of smoking | 76 (36.54) | 22 (38.60) | 0.705 | 25 (43.86) | 0.178 | 28 (35.00) | 0.716 | 28 (35.44) | 0.797 | History of drinking | 45 (21.63) | 10 (17.54) | 0.379 | 13 (22.81) | 0.801 | 15 (18.75) | 0.424 | 16 (20.25) | 0.705 | History of antiplatelet drugs | 14 (6.73) | 7 (12.28) | 0.050 | 7 (12.28) | 0.050 | 7 (8.75) | 0.358 | 10 (12.82) | 0.007 | History of anticoagulant drugs | 1 (0.48) | 0 (0.00) | 0.538 | 0 (0.00) | 0.538 | 0 (0.00) | 0.428 | 0 (0.00) | 0.437 | Time (IQR) | 6 (21) | 7 (21) | 0.287 | 5 (6) | 0.039 | 5 (11) | 0.167 | 6 (21) | 0.452 | | 60 (28.85) | 37 (64.91) | 0.222 | 30 (52.63) | <0.001 | 49 (61.25) | 0.013 | 51 (64.56) | 0.100 | Blood glucose (IQR) | 7.43 (4.04) | 7.91 (3.43) | 0.346 | 8.03 (4.09) | 0.02 | 7.97 (4.55) | 0.008 | 7.91 (4.61) | 0.024 | Basal ganglia | 100 (48.08) | 27 (47.37) | 0.900 | 26 (45.61) | 0.662 | 42 (52.50) | 0.313 | 31 (39.24) | 0.046 | Lobar | 62 (29.81) | 20 (35.09) | 0.306 | 18 (31.58) | 0.732 | 23 (28.75) | 0.792 | 28 (35.44) | 0.164 | Thalamus | 28 (13.46) | 6 (10.53) | 0.446 | 10 (17.54) | 0.289 | 11 (13.75) | 0.923 | 14 (17.72) | 0.159 | Cerebellum | 11 (5.29) | 3 (5.26) | 0.992 | 1 (1.75) | 0.162 | 4 (5.00) | 0.883 | 3 (3.80) | 0.452 | Brain stem | 4 (1.92) | 0 (0.00) | 0.215 | 2 (3.51) | 0.306 | 0 (0.00) | 0.110 | 1 (1.27) | 0.589 | PIVH | 1 (0.48) | 0 (0.00) | 0.538 | 0 (0.00) | 0.538 | 0 (0.00) | 0.428 | 1 (1.27) | 0.200 | Right-sided hematoma | 96 (46.15) | 27 (47.37) | 0.829 | 27 (47.37) | 0.829 | 33 (41.25) | 0.262 | 36 (45.57) | 0.895 | Insular involvement | 20 (9.62) | 10 (17.54) | 0.017 | 13 (22.81) | <0.001 | 9 (11.25) | 0.527 | 6 (7.59) | 0.439 | SIVH | 56 (26.92) | 16 (28.07) | 0.819 | 18 (31.58) | 0.352 | 30 (37.50) | 0.007 | 22 (27.85) | 0.814 | Hematoma ml | 87 (41.83) | 31 (54.38) | 0.024 | 30 (52.63) | 0.052 | 43 (53.75) | 0.006 | 36 (45.57) | 0.392 | Leukocytosis | 8 (3.85) | 0 (0.00) | 0.076 | 3 (5.26) | 0.514 | 3 (3.75) | 0.955 | 0 (0.00) | 0.025 | Low platelet count | 2 (0.96) | 1 (1.75) | 0.472 | 1 (1.75) | 0.472 | 1 (1.25) | 0.736 | 0 (0.00) | 0.271 | Abnormal hemoglobin level | 3 (1.44) | 1 (1.75) | 0.817 | 1 (1.75) | 0.817 | 2 (2.50) | 0.312 | 1 (1.28) | 0.881 | Coagulation abnormalities | 2 (0.96) | 0 (0.00) | 0.383 | 0 (0.00) | 0.383 | 0 (0.00) | 0.261 | 1 (1.28) | 0.714 | Mortality | 17 (8.17) | 6 (10.53) | 0.447 | 8 (14.03) | 0.058 | 8 (10.00) | 0.447 | 10 (12.65) | 0.058 |
|
|
ICH: intracerebral hemorrhage; SD: standard deviation; Time: time of onset on admission; GCS: Glasgow Coma Scale; PIVH: primary intraventricular hemorrhage; SIVH: secondary intraventricular hemorrhage; CK: creatine kinase; CKMB: creatine kinase-myocardial subfraction; LDH: lactic dehydrogenase; hs-cTnT: high-sensitive cardiac troponin T.
|